3Nikas S, Rizos E. Milionis H, et al. The effects of the addition of lossrtsn on uric acid metabolism in patients receiving indapsmide[J]. J Renin Angiotensin Aldosterone Syst, 2000; 1 (3) : 289.
4[ No authors listed]. Post-stroke antihypertensive treatment study.A preliminary result[J]. Chin Med J, 1995,108(9):710- 717.
5Curry CL,Robinson H, Brown R, et al. Regression of left ventricular hypertrophy in patients with essential hypertension. Results of 6 month treatment with indapamide[J ]. Am J Hypertens, 1996,9(8) :828 - 832.
6Gosse P, Sheridan DJ, Zannad F, et al. Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 rng versus enalapril 20 rng: the LIVE study[J ]. J Hypertens,2000,18(10) : 1465 - 1475.
7Gosse P,Sheridan DJ,Zannad F,et al.Regression of left ventricular hypertophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg:the LIVE study[ J ].J Hypertens,2000,18(10):1 465-1 475
81999 World Heahh Organization - International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee [J]. J nypertens, 1999; 17(2) : 151
9Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation [J] . Diabet Med, 1999; 15(7) : 539
10Ambrosioni E, Safar M, Degaute JP, et al. Low- dose antihypertensive therapy with 1.5mg sustained - release indaparnide : results of randomized double - blind controlled studies. European Study Group [J]. J Hypertens, 1998; 16 (11): 1677
